Publication | Closed Access

Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study

Bone DiseasePopulation-based StudyBone HealthHealth PolicyHealth EconomicsHealth Care ReimbursementNoncompliant UsersOutcomes ResearchPharmacoeconomicsOsteoporosisHealth Care FinancePublic HealthOsteoporotic FracturesMedicineOrthopaedic SurgeryHealth Services Research